CD274 and cancer: In the past, NTP has been combined with chemotherapy and even a therapeutic cancer vaccine.12, 21 We also suggest combining DBD plasma with other immunotherapeutic agents, particularly checkpoint inhibitors like PD‐1/PDL‐1 inhibitors, as ICD induction with DBD plasma may have a niche to further improve specific anticancer immune responses.